http://blogs.wsj.com/pharmalot/2014/07/08/former-novartis-exec-
Former Novartis Exec: I was Fired for Complaining About a Possible Kickback
...
Min Amy Guo, who had been executive director of the Health Economics and
Outcomes Research Group, two years ago objected to a proposed study that
would look at uses of the Affinitor breast cancer treatment that were not
approved by the FDA. This is also known as off-label use.
...
